Max Liebregts

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry

Josef Veselka, Morten K. Jensen, Max Liebregts et al. · European Heart Journal · 2016 · 200 citations · Full text

Medicine, Anesthesiology, Cardiology +12

Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Arend F. L. Schinkel, Max Liebregts et al. · Circulation Arrhythmia and Electrophysiology · 2015 · 138 citations

Medicine, Cardiology, Clinical Cardiology +16

Chloroquine-induced QTc prolongation in COVID-19 patients

Marcel P. H. van den Broek, Julia E. Möhlmann, B G S Abeln et al. · Netherlands Heart Journal · 2020 · 125 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Long-Term Outcomes After Medical and Invasive Treatment in Patients With Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Max Liebregts, Robbert Steggerda et al. · JACC Heart Failure · 2014 · 120 citations

Medicine, Cardiology, Internal Medicine +8

Periprocedural Complications and Long-Term Outcome After Alcohol Septal Ablation Versus Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy

Robbert Steggerda, Kevin Damman, Jippe C. Balt et al. · JACC: Cardiovascular Interventions · 2014 · 72 citations · Full text

Medicine, Cardiology, Surgery +8